Cofoe Medical Technology Co.,Ltd. (SHE:301087)

Market Cap	11.63B +50.6%
Revenue (ttm)	3.39B +13.6%
Net Income	371.61M +19.2%
EPS	1.81 +19.9%
Shares Out	203.20M
PE Ratio	31.61
Forward PE	25.89
Dividend	1.80 (3.20%)
Ex-Dividend Date	n/a

Volume	2,105,070
Average Volume	3,425,900
Open	56.30
Previous Close	56.29
Day's Range	55.70 - 57.23
52-Week Range	29.17 - 63.99
Beta	1.04
RSI	48.14
Earnings Date	Mar 10, 2026

About Cofoe Medical Technology

Cofoe Medical Technology Co.,Ltd. engages in the research and development, production, sales, and service of medical devices in China. The company offers diagnosis and respires products, including blood pressure monitors, thermometers, nebulizers, oxygen concentrators, fingertip pulse oximeters, fetal doppler, and CPAP and BPAP devices; and in vitro diagnostic products, such as glucose meter, HCG test kits, H.Pylori, UTM, DNA/RNA extraction reagents, and respiratory tract infections. It also provides wheelchair, commode chair, hospital beds, ai...

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 2005
• Employees: 5,081
• Stock Exchange: Shenzhen Stock Exchange
• Ticker Symbol: 301087

Financial Performance

In 2025, Cofoe Medical Technology's revenue was 3.39 billion, an increase of 13.56% compared to the previous year's 2.98 billion. Earnings were 371.61 million, an increase of 19.20%.